Changes in female cancer diagnostic billing rates over the COVID-19 period in the Ontario Health Insurance Plan

Background: The initial response to coronavirus disease 2019 (COVID-19) in Ontario included suspension of cancer screening programs and deferral of diagnostic procedures and many treatments. Although the short-term impact of these measures on female cancers is well documented, few studies have asses...

Full description

Saved in:
Bibliographic Details
Main Authors: Deanna McLeod, Ilidio Martins, Anna V. Tinker, Amanda Selk, Christine Brezden-Masley, Nathalie LeVasseur, Alon D. Altman
Format: Article
Language:English
Published: SAGE Publishing 2025-05-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359251339919
Tags: Add Tag
No Tags, Be the first to tag this record!